Cutaneous T cell lymphoma complicating severe atopic dermatitis: Is making a diagnosis the main challenge?

Dermatology

Volumn 218, Issue 2, 2009, Pages 168-171

  Meyer, Nicolas ^a,b   Mazereeuw Hautier, Juliette ^a   Launay, François ^a   Lamant, Laurence ^a   Paul, Carle ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b CHU PURPAN   (France)

Author keywords

Atopic dermatitis; Calcineurin inhibitors; CD30 positive lymphocytes; Cutaneous T cell lymphoma

Indexed keywords

ALPHA INTERFERON; ANTIHISTAMINIC AGENT; CORTICOSTEROID; METHOTREXATE; PSORALEN;

ADULT; ARTICLE; ATOPIC DERMATITIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PUVA; SKIN BIOPSY; SKIN DEFECT; SKIN LYMPHOMA; ULTRAVIOLET B RADIATION;

DERMATITIS, ATOPIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 59049084849     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000182251     Document Type: Article

References (22)

1. McWhorter WP: Allergy and risk of cancer: a prospective study using NHANESI follow up data. Cancer 1988;62:451-455.
2. Söderberg KC, Hagmar L, Schwartzbaum J, Feychting M: Allergic conditions and risk of hematological malignancies in adults: a cohort study. BMC Public Health 2004;4:51.
3. Eriksson NE, Holmen A, Hogstedt B, Mikoczy Z, Hagmar L: A prospective study of cancer incidence in a prospective cohort examined for allergy. Allergy 1995;50:718-722.
4. Talbot-Smith A, Fritschi L, Divitini ML, Mallon DF, Knuiman MW: Allergy, atopy and cancer: a prospective study of the 1981 Busselton cohort. Am J Epidemiol 2003;157:606-612.
5. Cartwright RA, McKinney PA, O'Brien C, Richards ID, Roberts B, et al: Non-Hodgkin's lymphoma: case control epidemiological study in Yorkshire. Leuk Res 1988;12:81-88.
6. Mehrany K, El-Azhary RA, Bouwhuis SA, Pittelkow MR: Cutaneous T-cell lymphoma and atopy: is there an association? Br J Dermatol 2003;149:1013-1017.
7. McGregor JM, Crook T, Fraser-Andrews EA, Rozycka M, Crossland S, Brooks L, et al: Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas. J Invest Dermatol 1999;112:317-321.
8. Li G, Chooback L, Wolfe JT, Rook AH, Felix CA, Lessin SR, et al: Overexpression of p53 protein in cutaneous T cell lymphoma. J Invest Dermatol 1998;110:767-770.
9. Mougel FR, Dalle S, Balme B, Houot R, Thomas L: Aggressive CD30 large cell lymphoma after cyclosporine given for putative atopic dermatitis. Dermatology 2006;213:239-241.
10. Laube S, Stephens M, Smith AG, Whittaker SJ, Tan BB: Lymphomatoid papulosis in a patient with atopic eczema on long-term ciclosporin therapy. Br J Dermatol 2005;152:1346-1348.
11. Fletcher CL, Orchard GE, Hubbard V, Whittaker SJ, Edelson RL, Russell-Jones R: CD30(+) cutaneous lymphoma in association with atopic eczema. Arch Dermatol 2004;140:449-454.
12. Kirby B, Owen CM, Blewitt RW, Yates VM: Cutaneous T-cell lymphoma developing in a patient on cyclosporin therapy. J Am Acad Dermatol 2002;47:S165-S167.
13. Pielop JA, Jones D, Duvic M: Transient CD30+ nodal transformation of cutaneous T-cell lymphoma associated with cyclosporine treatment. Int J Dermatol 2001;40:505-511.
14. Van Haselen CW, Toonstra J, Preesman AH, Van Der Putte SC, Bruijnzeel-Koomen CA, Van Vloten WA: Sézary syndrome in a young man with severe atopic dermatitis. Br J Dermatol 1999;140:704-707.
15. Rajka G, Winkelmann RK: Atopic dermatitis and Sézary syndrome. Arch Dermatol 1984;120:83-84.
16. Abel EA, Nickoloff BJ, Shelby DM, Watson W, Wood GS: Tumor stage mycosis fungoides in a patient treated with long-term corticosteroids for asthma and atopic-like dermatitis. J Dermatol Surg Oncol 1986;12:1089-1093.
17. Lange-Vejlsgaard G, Ralfkiaer E, Larsen JK, O'Connor N, Thomsen K: Fatal cutaneous T cell lymphoma in a child with atopic dermatitis. J Am Acad Dermatol 1989;20:954-958.
18. Fischer M, Harvima IT, Carvalho RF, Möller C, Naukkarinen A, Enblad G, et al: Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. J Clin Invest 2006;116:2748-2756.
19. US Food and Drug Administration: FDA Public Health Advisory: elidel (pimecrolimus) cream and protopic (tacrolimus) ointment. 2005. http://www.fda.gov/cder/drug/advisory/elidel-protopic.htm (accessed October 31, 2008).
20. Ormerod AD: Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern? Br J Dermatol 2005;153:701-705.
21. Arellano FM, Wentworth CE, Arana A, Fernadez C, Paul CF: Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol 2007;127:808-816.
22. Jackow CM, Cather JC, Hearne V, Asano AT, Musser JM, Duvic M: Association of erythrodermic CTCL, superantigen-positive Staphylococcus aureus , and oligoclonal Tcell receptor V gene expansion. Blood 1997;89:32-40.